ScandicNeuro Corp

ScandicNeuro Corp Consultation/Research SNC is a consultation and research company with an expertise in neuropsychology. All services are provided in English and Swedish.

The company provides multiple consulting services, including (but not limited to): sampling source documentation and audio recordings of assessment sessions to identify and correct deviations from administration and scoring conventions, rater feedback, education, expert opinions, language translation services, and development of training documents and procedures. SNC has extensive experience with

global clinical trials research and is actively involved in a diverse portfolio of clinical trials focused on Alzheimer's disease, Mild Cognitive Impairment, brain injury, depression, schizophrenia, virtual assessments, etc. To find out more info about our projects or services, go to www.scandicneuro.com.

The treatment gap in the U.S. underpins nearly every employer mental health conversation. SAMHSA’s 2024 National Survey ...
08/31/2026

The treatment gap in the U.S. underpins nearly every employer mental health conversation. SAMHSA’s 2024 National Survey on Drug Use and Health found that 61.5 million adults (23.4% of the US adult population) experienced any mental illness in 2024, yet only about 52% received treatment. That means roughly 29.5 million adults with a diagnosable condition received no care. Access and insurance coverage remain a core problem.

The gap between rising demand and falling investment is widening, and brokers have a clear role at renewal

Alzheimer's Disease trial recruitment was consistently characterized as a multi-stage, interconnected process that inclu...
08/10/2026

Alzheimer's Disease trial recruitment was consistently characterized as a multi-stage, interconnected process that includes participant identification, outreach, pre-screening, engagement, screening, and retention by the five interview groups in this study. It was noted that no single strategy or tool was considered adequate to guarantee successful recruitment.

Interviews with stakeholders across the Alzheimer’s clinical trial ecosystem explored barriers, emerging practices and opportunities to improve recruitment. - August 7, 2026

The FDA has just approved a wireless brain implant for severe depression—imagine it as your brain’s first true smart upg...
04/30/2026

The FDA has just approved a wireless brain implant for severe depression—imagine it as your brain’s first true smart upgrade. It takes 20 minutes to implant in an outpatient clinic, and it’s not a bulky medical gadget; it’s even smaller than an AirPod and operates without batteries or wires running through your head.

Brain implant gets FDA clearance for first wireless depression treatment trial, offering battery-free stimulation in 20-minute outpatient procedure.

04/21/2026

Exciting News! Exciting News! April 21, 2026 s11admin Exciting news! Dr. Dobson felt both honored and humbled to be named an inaugural Fellow of the International Neuropsychological Society (INS) at the 2026 INS Annual Conference in Philadelphia, in the company of many distinguished and highly respe...

In what ways can neuropsychology add value to global clinical trial research?
03/04/2026

In what ways can neuropsychology add value to global clinical trial research?

In what ways can neuropsychology add value to global clinical trial research? In what ways can neuropsychology add value to global clinical trial research? March 4, 2026 s11admin In what ways can neuropsychology add value to global clinical trial research? Neuropsychology supports global clinical tr...

Happy New Year!We wish you prosperity and success in the New Year and look forward to an exciting and inspiring 2026!
12/31/2025

Happy New Year!
We wish you prosperity and success in the New Year and look forward to an exciting and inspiring 2026!

A study from the University of Pittsburgh and UPMC Children’s Hospital has identified an epigenetic signature to help tr...
12/15/2025

A study from the University of Pittsburgh and UPMC Children’s Hospital has identified an epigenetic signature to help track and improve recovery after pediatric traumatic brain injury (TBI). Published in the Journal of Neurotrauma, it’s the first to reveal DNA changes that distinguish children with complicated mild to severe TBI from those with non-neurological injuries.
https://www.health.pitt.edu/news/pitt-study-finds-signature-pediatric-brain-injury

Scientists have built the first “artificial neuron” made from a metal–organic framework (M*F) that can behave like real ...
09/05/2025

Scientists have built the first “artificial neuron” made from a metal–organic framework (M*F) that can behave like real brain cells in water by responding to dopamine. Unlike traditional electronic devices, this M*F neuron can carry out brain-like tasks such as learning through synaptic plasticity, sending integrate-and-fire signals, and adjusting its activity based on dopamine levels.

To demonstrate its capabilities, the team utilized the neuron to control a robotic hand. The amount of dopamine present determined how fast and how strongly the hand moved. This breakthrough brings artificial neurons a significant step closer to functioning like biological ones, opening up exciting possibilities for brain-inspired computers, smart biosensors, and advanced prosthetic devices.

This study presents the first metal-organic framework neuron with real neurotransmitter dopamine tunable spikes for neuromorphic engineering.

05/28/2025

Address

7700 Congress Avenue, Suite 1136
Boca Raton, FL
33487

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+18887226342

Alerts

Be the first to know and let us send you an email when ScandicNeuro Corp posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ScandicNeuro Corp:

Shortcuts

Featured

Share